This metabolic brain boost revives memory in Alzheimer’s mice
An experimental cancer drug that helps the brain turn glucose into energy was able to reverse memory loss in a mouse model of Alzheimer’s disease.
amyloid
New blood tests can help diagnose Alzheimer's. Are doctors ready for what's next?
A new generation of blood tests can help diagnose Alzheimer’s disease. But many doctors don’t yet know how to use them.
A protein called Reelin keeps popping up in brains that resist aging and Alzheimer’s
Early in life, the protein Reelin helps assemble the brain. Later on, it appears to protect the organ from Alzheimer’s and other threats to memory and thinking.
Blood tests can help diagnose Alzheimer's — if they're accurate enough. Not all are
A new generation of blood tests can help doctors diagnose Alzheimer's without a brain scan or spinal tap. But only a few perform as well as traditional tests.
An experimental Alzheimer's drug outperforms one just approved by the FDA
In a large study, the experimental drug donanemab slowed the progression of Alzheimer's by about 35%. That's slightly better than the drug Leqembi, which was fully approved by the FDA on July 6.
Study: Alzheimer's drug shows modest success slowing declines in memory, thinking
In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.
What causes Alzheimer's? Study puts leading theory to 'ultimate test'
Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease.
FDA Poised For Decision On Controversial Alzheimer's Drug
The FDA has until Monday to decide whether to approve the first new Alzheimer's drug in nearly two decades. Two big studies of the drug produced conflicting results.
New Markers For Alzheimer's Disease Could Aid Diagnosis And Speed Up Drug Development
Researchers are using brain scans, blood and spinal fluid to detect early signs of Alzheimer's disease. These "biomarkers" may also offer a quicker way to test new Alzheimer's drugs.
After A Big Failure, Scientists And Patients Hunt For A New Type Of Alzheimer's Drug
Now that so many experimental drugs targeting amyloid-beta have bombed, scientists are looking for different approaches for treating Alzheimer's, including a drug that failed as a cancer treatment.